YBX1 and cancer: CircNEIL3 directly acts on YB1, promoting Nedd4L-mediated proteasome elevation to enzymatically degrade oncogenic protein YB1, thereby reducing YB1 levels and exerting an inhibitory effect on cancer metastasis (92, 93).